- Home
- TLX vs SEZL Comparison
TLX vs SEZL Comparison
Compare TLX & SEZL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLX
- SEZL
- Stock Information
- Founded
- TLX 2015
- SEZL 2016
- Country
- TLX Australia
- SEZL United States
- Employees
- TLX N/A
- SEZL N/A
- Industry
- TLX Biotechnology: Pharmaceutical Preparations
- SEZL Diversified Financial Services
- Sector
- TLX Health Care
- SEZL Finance
- Exchange
- TLX Nasdaq
- SEZL Nasdaq
- Market Cap
- TLX 3.6B
- SEZL 3.0B
- IPO Year
- TLX N/A
- SEZL N/A
- Fundamental
- Price
- TLX $10.63
- SEZL $65.36
- Analyst Decision
- TLX Strong Buy
- SEZL Buy
- Analyst Count
- TLX 4
- SEZL 4
- Target Price
- TLX $21.00
- SEZL $113.75
- AVG Volume (30 Days)
- TLX 109.9K
- SEZL 709.8K
- Earning Date
- TLX 01-01-0001
- SEZL 11-05-2025
- Dividend Yield
- TLX N/A
- SEZL N/A
- EPS Growth
- TLX N/A
- SEZL 146.46
- EPS
- TLX 0.04
- SEZL 2.93
- Revenue
- TLX $664,225,558.00
- SEZL $371,794,890.00
- Revenue This Year
- TLX N/A
- SEZL $65.77
- Revenue Next Year
- TLX N/A
- SEZL $27.29
- P/E Ratio
- TLX $333.76
- SEZL $23.97
- Revenue Growth
- TLX 55.35
- SEZL 92.95
- 52 Week Low
- TLX $8.93
- SEZL $24.86
- 52 Week High
- TLX $30.36
- SEZL $186.74
- Technical
- Relative Strength Index (RSI)
- TLX 52.01
- SEZL 28.00
- Support Level
- TLX $10.74
- SEZL $70.63
- Resistance Level
- TLX $11.00
- SEZL $80.00
- Average True Range (ATR)
- TLX 0.28
- SEZL 4.46
- MACD
- TLX 0.04
- SEZL -0.26
- Stochastic Oscillator
- TLX 63.77
- SEZL 0.00
About TLX Telix Pharmaceuticals Limited American Depositary Shares
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
About SEZL Sezzle Inc.
Sezzle Inc is a financing institution that offers technology-driven payment platform. It allows customers to split their purchase into four installments and pay over 6 weeks with only the first payment due at the time of purchase. Companies operations comprise one reportable segment, the majority of which derives revenue from payment processing platform in North America.